{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:58:06Z","timestamp":1781179086718,"version":"3.54.1"},"reference-count":17,"publisher":"Scientific Scholar","issue":"03","license":[{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":299,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["South Asian J Cancer"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Purpose\u2003The purpose of the study was to evaluate the short-term response and acute toxicities in muscle-invasive carcinoma urinary bladder treated with neoadjuvant chemotherapy followed by concurrent chemoradiation.<\/jats:p>\n                  <jats:p>Materials and Methods\u2003Thirty patients with muscle-invasive bladder cancer were treated with three cycles of neoadjuvant chemotherapy every 3 weeks. Response assessment was done after 4 weeks with repeat cystoscopy and imaging. Responders were treated with concurrent chemoradiation 60 Gy\/30# at 2 Gy\/# along with weekly injection cisplatin 35 mg\/m2. Response assessment was done by new response evaluation criteria in solid tumors (version 1.1). Treatment-related acute toxicities were scored using common terminology criteria for adverse events version 4.0.<\/jats:p>\n                  <jats:p>Results\u2003Of the 30 patients, 25 patients responded to neoadjuvant chemotherapy with complete response in 17 patients (56.67%) and partial response in eight patients (26.66%). Five patients (16.66%) showed poor response and were advised radical cystectomy, of which four underwent radical cystectomy and one patient opted for concurrent chemoradiation. Of 26 patients who completed chemoradiation, complete response was seen in 21 patients (80.76%) and partial response was seen in four patients (15.38%). Only one patient developed progression of disease in the form of lung metastasis. All the patients with residual disease were advised to undergo salvage cystectomy. Among the patients receiving chemoradiation, grade 2 cystitis and diarrhea was seen in 10 patients (38.46%) and four patients (15.38%), respectively. Only one patient developed grade 3 diarrhea.<\/jats:p>\n                  <jats:p>Conclusion\u2003Bladder preservation treatment is an effective, safe, and convenient option for patients presenting with muscle-invasive carcinoma bladder. Neoadjuvant chemotherapy followed by chemoradiation was well-tolerated with an acceptable rate of complications.<\/jats:p>","DOI":"10.1055\/s-0041-1723076","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T18:35:45Z","timestamp":1619462145000},"page":"121-125","source":"Crossref","is-referenced-by-count":3,"title":["Bladder Preservation with Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for the Treatment of Muscle-invasive Carcinoma of the Bladder: A Single-Center Experience"],"prefix":"10.25259","volume":"09","author":[{"given":"Chinmayee","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Research Institute, SRHU, Dehradun, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Bansal","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Research Institute, SRHU, Dehradun, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Biswas","sequence":"additional","affiliation":[{"name":"Department of General Surgery, HIMS, SRHU, Dehradun, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenu","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Research Institute, SRHU, Dehradun, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Nautiyal","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Research Institute, SRHU, Dehradun, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushtaq","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Research Institute, SRHU, Dehradun, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3747\/co.v16i4.411","article-title":"Conservative treatment of invasive bladder cancer","volume":"16","author":"N J Rene","year":"2009","journal-title":"Curr Oncol"},{"issue":"03","key":"ref2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1756287211407543","article-title":"Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy","volume":"3","author":"A Balar","year":"2011","journal-title":"Ther Adv Urol"},{"issue":"02","key":"ref3","first-page":"854","article-title":"Radiotherapy in muscle-invasive bladder cancer: the latest research progress and clinical application","volume":"5","author":"S Zhang","year":"2015","journal-title":"Am J Cancer Res"},{"issue":"S 03","key":"ref4","doi-asserted-by":"crossref","first-page":"iii40","DOI":"10.1093\/annonc\/mdu223","article-title":"Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"J Bellmunt","year":"2014","journal-title":"Ann Oncol"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients","volume":"19","author":"J P Stein","year":"2001","journal-title":"J Clin Oncol"},{"key":"ref6","first-page":"14","article-title":"Tri-modality treatment in muscle invasive bladder cancer - What is the current status","volume":"9","author":"K Beena","year":"2013","journal-title":"Amrita J Med"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/bjc.2015.109","article-title":"Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder","volume":"112","author":"S Hafeez","year":"2015","journal-title":"Br J Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4172\/2155-9619.1000121","article-title":"Bladder preservation with concurrent radiotherapy and gemcitabine following maximal transurethral resection for muscle invasive bladder cancer: single institutional experience","volume":"3","author":"M A Tunio","year":"2012","journal-title":"J Nucl Med Radiat Ther"},{"issue":"09","key":"ref9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"H B Grossman","year":"2003","journal-title":"N Engl J Med"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-5347(17)48996-8","article-title":"Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium","volume":"133","author":"C N Sternberg","year":"1985","journal-title":"J Urol"},{"issue":"03","key":"ref11","first-page":"334","article-title":"Organ preservation in muscle-invasive bladder cancer","volume":"19","author":"S A Fernando","year":"2005","journal-title":"Oncology (Williston Park)"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.eururo.2005.04.006","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration","volume":"48","author":"Advanced Bladder Cancer (ABC) Meta-analysis Collaboration","year":"2005","journal-title":"Eur Urol"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/cncr.23137","article-title":"Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: a multi-institutional, long-term experience","volume":"112","author":"S Perdon\u00e0","year":"2008","journal-title":"Cancer"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2015.09.030","article-title":"Long-term outcomes among patients who achieve complete or near-complete responses after the induction phase of bladder-preserving combined-modality therapy for muscle-invasive bladder cancer: A pooled analysis of NRG oncology\/RTOG 9906 and 0233","volume":"94","author":"T Mitin","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"01","key":"ref15","first-page":"6","article-title":"Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer: experience at Sindh Institute of Urology & Transplantation (SIUT)","volume":"61","author":"M A Tunio","year":"2011","journal-title":"J Pak Med Assoc"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.urolonc.2008.07.005","article-title":"Combined modality treatment with bladder preservation for muscle invasive bladder cancer","volume":"28","author":"M A Sabaa","year":"2010","journal-title":"Urol Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1507-1367(10)60016-8","article-title":"Conservative treatment in patients with muscle-invasive bladder cancer by transurethral resection, neoadjuvant chemotherapy with gemcitabine and cisplatin, and accelerated radiotherapy with concomitant boost plus concurrent cisplatin assessment of response and toxicity","volume":"13","author":"J N Sadzikowska","year":"2008","journal-title":"Rep Pract Oncol Radiother"}],"container-title":["South Asian Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1723076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:12:17Z","timestamp":1781176337000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.sajc.org\/bladder-preservation-with-neoadjuvant-chemotherapy-followed-by-concurrent-chemoradiation-for-the-treatment-of-muscle-invasive-carcinoma-of-the-bladder-a-single-center-experience\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":17,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2021,4,26]]},"published-print":{"date-parts":[[2020,7]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1723076","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2278-330X","2278-4306"],"issn-type":[{"value":"2278-330X","type":"print"},{"value":"2278-4306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}